News

IGDRASOL had earlier acquired exclusive US distribution rights to Cynviloq, which is a next-generation, branded, micellar diblock copolymeric paclitaxel formulation currently approved and marketed in several countries, including

The entity group that includes affiliates of Greenspring Associates, QIC Global Private Equity, and Thomas McNerney & Partners was formed to acquire the AmerisourceBergen’s contract packaging business. The

The company and its affiliates agreed to settle the alleged civil violations of the False Claims Act with the US. Ranbaxy USA has agreed to plead guilty to

The rejection follows the company’s previously dismissed proposal to install wind turbines at the facility. The company, which has accepted the decision, is working with Marine Scotland to

As per the agreement, the new JV will be named Amgen-Beta Pharmaceuticals and Zhejiang Beta Pharma will own 51% while Amgen will own the remaining 49% interest in

Marina Biotech research and development executive vice president Richard Ho said the SMARTICLES delivery technology is advancing into another clinical development effort. "With the initiation of this trial,

MOR208’s efficacy in patients with relapsed or refractory NHL will be assessed in the open-label, multicentre trial. MorphoSys chief development officer Dr. Arndt Schottelius said MOR208 cancer program

The investigational, oral, dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2) completed the open-label, pioneer portion of the trial. Lexicon president and chief executive

DKSH provides contract sales services in both private clinics and trade channel for the antibiotic product line of GlaxoSmithKline. GlaxoSmithKline (Hong Kong) vice president and general manager Sally